Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 48
Filtrar
1.
Parasitol Res ; 119(9): 3093-3097, 2020 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-32591863

RESUMO

The efficacy of pyrantel pamoate, pyrvinium pamoate, ivermectin, and piperazine citrate against pinworm in cockroach was evaluated. Laboratory-reared German cockroaches naturally infected with Blatticola blattae were treated with the anthelmintics and necropsied at 3 to 35 days after treatment. Ivermectin at over 5 ppm and piperazine citrate at over 2000 ppm killed all the treated cockroaches. Pinworms were still detected in cockroaches given lower concentration of the aforementioned drugs. Administration of pyrantel pamoate (100-1000 ppm) and pyrvinium pamoate (2000 ppm) did not kill the cockroaches, and no pinworms were detected at 3 and 17 days after treatment. Thus, pyrantel pamoate and pyrvinium pamoate were found to be effective for deworming B. blattae in the German cockroaches, without causing mortality for the host. Our results showed that anthelmintics selection is essential for eradication of pinworms in cockroaches because of the toxicity for the host such as ivermectin or piperazine citrate. This is the first report of piperazine citrate toxicity in cockroaches.


Assuntos
Anti-Helmínticos/farmacologia , Baratas/parasitologia , Enterobíase/parasitologia , Enterobius/efeitos dos fármacos , Animais , Avaliação Pré-Clínica de Medicamentos , Enterobíase/tratamento farmacológico , Enterobius/fisiologia , Humanos , Ivermectina/farmacologia , Piperazinas/farmacologia , Pamoato de Pirantel/farmacologia
2.
Pediatr Infect Dis J ; 39(3): 254-255, 2020 03.
Artigo em Inglês | MEDLINE | ID: mdl-32032311

RESUMO

We describe the case of a 7-year-old girl with repeated vaginal Enterobius vermicularis infection, never detected as a digestive tract infection. Two-dose pyrantel pamoate or 2-dose albendazole could not suppress recurrence. Finally, 3-dose albendazole after 2-week intervals was successful in preventing relapse.


Assuntos
Albendazol/uso terapêutico , Antiprotozoários/uso terapêutico , Enterobius/efeitos dos fármacos , Oxiuríase/tratamento farmacológico , Oxiuríase/parasitologia , Vaginite/tratamento farmacológico , Vaginite/parasitologia , Albendazol/administração & dosagem , Animais , Antiprotozoários/administração & dosagem , Criança , Esquema de Medicação , Feminino , Humanos , Oxiuríase/transmissão , Recidiva , Resultado do Tratamento
4.
PLoS Negl Trop Dis ; 11(9): e0005963, 2017 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-28945752

RESUMO

BACKGROUND: Previous studies on the association of enterobiasis and chronic inflammatory diseases have revealed contradictory results. The interaction of Enterobius vermicularis infection in particular with gut microbiota and induced immune responses has never been thoroughly examined. METHODOLOGY/FINDINGS: In order to answer the question of whether exposure to pinworm and mebendazole can shift the intestinal microbial composition and immune responses, we recruited 109 (30 pinworm-negative, 79 pinworm-infected) first and fourth grade primary school children in Taichung, Taiwan, for a gut microbiome study and an intestinal cytokine and SIgA analysis. In the pinworm-infected individuals, fecal samples were collected again at 2 weeks after administration of 100 mg mebendazole. Gut microbiota diversity increased after Enterobius infection, and it peaked after administration of mebendazole. At the phylum level, pinworm infection and mebendazole deworming were associated with a decreased relative abundance of Fusobacteria and an increased proportion of Actinobacteria. At the genus level, the relative abundance of the probiotic Bifidobacterium increased after enterobiasis and mebendazole treatment. The intestinal SIgA level was found to be lower in the pinworm-infected group, and was elevated in half of the mebendazole-treated group. A higher proportion of pre-treatment Salmonella spp. was associated with a non-increase in SIgA after mebendazole deworming treatment. CONCLUSIONS/SIGNIFICANCE: Childhood exposure to pinworm plus mebendazole is associated with increased bacterial diversity, an increased abundance of Actinobacteria including the probiotic Bifidobacterium, and a decreased proportion of Fusobacteria. The gut SIgA level was lower in the pinworm-infected group, and was increased in half of the individuals after mebendazole deworming treatment.


Assuntos
Citocinas/imunologia , Enterobíase/tratamento farmacológico , Enterobíase/imunologia , Enterobius/efeitos dos fármacos , Microbioma Gastrointestinal/efeitos dos fármacos , Mebendazol/uso terapêutico , Animais , Bifidobacterium/efeitos dos fármacos , Bifidobacterium/genética , Bifidobacterium/crescimento & desenvolvimento , Bifidobacterium/isolamento & purificação , Criança , Pré-Escolar , Biologia Computacional , Citocinas/biossíntese , Enterobíase/microbiologia , Enterobíase/parasitologia , Enterobius/genética , Enterobius/imunologia , Fezes/parasitologia , Feminino , Fusobactérias/efeitos dos fármacos , Fusobactérias/genética , Fusobactérias/crescimento & desenvolvimento , Fusobactérias/isolamento & purificação , Microbioma Gastrointestinal/genética , Humanos , Imunidade/efeitos dos fármacos , Imunoglobulina A Secretora/análise , Imunoglobulina A Secretora/imunologia , Intestinos/efeitos dos fármacos , Intestinos/imunologia , Intestinos/microbiologia , Intestinos/parasitologia , Masculino , Mebendazol/administração & dosagem , Salmonella/efeitos dos fármacos , Salmonella/genética , Salmonella/crescimento & desenvolvimento , Salmonella/isolamento & purificação , Taiwan/epidemiologia
5.
Appl Environ Microbiol ; 83(11)2017 06 01.
Artigo em Inglês | MEDLINE | ID: mdl-28341675

RESUMO

Significant effort has gone into assessing the fate and removal of viruses, bacteria, and protozoan parasites during wastewater treatment to provide data addressing potential health risks associated with reuse options. Comparatively less is known about the fate of parasitic worm species ova in these complex systems. It is largely assumed that these helminths settle, are removed with the sludge, and consequently represent a relatively low risk for wastewater reuse applications. However, helminths are a highly diverse group of organisms that display a wide range of physical properties that complicate the application of a single treatment for helminth reduction during wastewater treatment. Moreover, their diverse biological and physical properties make some ova highly resistant to both disinfection (i.e., with chlorine or UV treatment) and physical removal (settling) through the wastewater treatment train, indicating that there may be reason to broaden the scope of our investigations into whether parasitic worm eggs can be identified in treated wastewater. The ubiquitous human parasitic nematode Enterobius vermicularis (pinworm) produces small, buoyant ova. Utilizing a novel diagnostic quantitative PCR (qPCR), this study monitored E. vermicularis presence at two full-scale wastewater treatment plants over the course of 8 months and demonstrated incomplete physical removal of E. vermicularis ova through tertiary treatment, with removal efficiencies approximating only 0.5 and 1.6 log10 at the two wastewater treatment plants based on qPCR. These findings demonstrate the need for more-diverse surrogates of helminthic ova to fully assess treatment performance with respect to reclaimed wastewaters.IMPORTANCE Helminths, despite being a diverse and environmentally resistant class of pathogens, are often underestimated and ignored when treatment performance at modern wastewater treatment plants is considered. A one-size-fits-all surrogate for removal of helminth ova may be inappropriate to adequately assess risk and ensure public safety when treated and partially treated wastewaters are encountered. This study argues for the use of human pinworm as a conservative indicator of the presence of helminth ova due to its small size, buoyancy, prevalence in humans, and environmental resistance.


Assuntos
Enterobius/isolamento & purificação , Águas Residuárias/parasitologia , Animais , Enterobius/efeitos dos fármacos , Enterobius/genética , Enterobius/crescimento & desenvolvimento , Óvulo/efeitos dos fármacos , Óvulo/crescimento & desenvolvimento , Esgotos/parasitologia , Purificação da Água
7.
Vet Parasitol ; 229: 73-75, 2016 Oct 15.
Artigo em Inglês | MEDLINE | ID: mdl-27809982

RESUMO

Drug resistance in equine gastro-intestinal parasitic nematodes has been reported throughout the world. While the focus is usually put on cyathostomins, observations of macrocylic lactone failure against Oxyuris equi have accumulated over the last decade. Here we report the failure of ivermectin in the control of O. equi in an experimental Welsh pony herd. In a first trial, 6 ponies previously drenched with moxidectin and showing patent O. equi infections were administered ivermectin and subsequently monitored for O. equi egg excretion over one month. This trial demonstrated a failure of ivermectin to control O. equi egg excretion as half of ponies demonstrated recurrent egg excretion in the peri-anal region during 21days after treatment. One year later, six female Welsh ponies drenched with moxidectin demonstrated signs of itching and scratching in their peri-anal region with worms being found transiently in fecal materials three weeks later. Ponies were allocated to three treatment groups, i.e. ivermectin, pyrantel embonate and fenbendazole and monitored for egg excretion over five weeks. Fenbendazole and pyrantel embonate broke ivermectin suboptimal efficacy as soon as 8 and 14days respectively after treatment, while egg excretion remained constant throughout the 41-day long trial in the ivermectin-treated ponies. This is the first report of ivermectin failure against O. equi in France. In the absence of critical efficacy test, it remains unclear whether true resistance is at stake or if these observations confound a constitutive suboptimal efficacy of ivermectin against O. equi.


Assuntos
Anti-Helmínticos/uso terapêutico , Resistência a Medicamentos , Enterobíase/veterinária , Enterobius , Doenças dos Cavalos/tratamento farmacológico , Ivermectina/uso terapêutico , Animais , Anti-Helmínticos/administração & dosagem , Enterobíase/tratamento farmacológico , Enterobíase/parasitologia , Enterobius/efeitos dos fármacos , Feminino , Fenbendazol/administração & dosagem , Fenbendazol/uso terapêutico , França/epidemiologia , Doenças dos Cavalos/epidemiologia , Doenças dos Cavalos/parasitologia , Cavalos , Ivermectina/administração & dosagem , Ivermectina/farmacologia , Pamoato de Pirantel/administração & dosagem , Pamoato de Pirantel/uso terapêutico
8.
Int J Infect Dis ; 49: 59-61, 2016 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-27263118

RESUMO

OBJECTIVES: Dientamoeba fragilis is a pathogenic protozoan of the human gastrointestinal tract with a worldwide distribution, which has emerged as an important and misdiagnosed cause of chronic gastrointestinal illnesses such as diarrhea and 'irritable-bowel-like' gastrointestinal disease. Very little research has been conducted on the use of suitable antimicrobial compounds. Furthermore, higher rates of co-infection with Enterobius vermicularis have been described, suggesting that E. vermicularis could influence the treatment of D. fragilis-infected patients. To study this, the treatment of E. vermicularis and D. fragilis co-infected patients was evaluated. METHODS: Forty-nine patients with a D. fragilis infection, including 25 (51.0%) patients co-infected with E. vermicularis, were studied. All of them were treated with metronidazole. Patients with E. vermicularis co-infection and/or an E. vermicularis-positive case in the family were treated with mebendazole. RESULTS: Metronidazole treatment failure was significantly more frequent in patients with E. vermicularis co-infection and in patients with children in the family. CONCLUSIONS: Co-infection with E. vermicularis may act as a factor favoring D. fragilis infection by preventing eradication measures. This suggests that both parasites should be treated simultaneously.


Assuntos
Coinfecção/tratamento farmacológico , Dientamoeba/efeitos dos fármacos , Dientamebíase/tratamento farmacológico , Enterobíase/tratamento farmacológico , Enterobius/efeitos dos fármacos , Adolescente , Adulto , Idoso , Animais , Anti-Helmínticos/administração & dosagem , Antiprotozoários , Criança , Pré-Escolar , Coinfecção/parasitologia , Dientamoeba/fisiologia , Dientamebíase/parasitologia , Enterobíase/parasitologia , Enterobius/parasitologia , Fezes/parasitologia , Feminino , Humanos , Masculino , Mebendazol/administração & dosagem , Metronidazol/administração & dosagem , Pessoa de Meia-Idade , Adulto Jovem
9.
J Paediatr Child Health ; 49(2): 138-40, 2013 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-23331477

RESUMO

AIM: To propose an aetiology and treatment for distressing perineal and vaginal pain in a paediatric female population. METHODS: Between 1997 and 2011, we saw 24 prepubertal girls (mean age of seven years, 11 months) with distressing vaginal pain, both before and after we suspected that pinworms (Enterobius vermicularis) were the cause. RESULTS: Prior to 2005, two of six girls had resolution of their symptoms, one of whom had repeated courses of mebendazole. After 2005, when pinworms were discovered in one patient, treatment with mebendazole 100 mg weekly for three weeks resolved symptoms in 18 girls. Three girls had a recurrence of symptoms within 2-4 months, and repeat treatment with mebendazole was successful. CONCLUSIONS: Pinworms should be considered when prepubertal girls present with distressing perineal or vaginal pain, and treatment with weekly mebendazole should be offered.


Assuntos
Enterobíase/diagnóstico , Dor Pélvica/parasitologia , Períneo/parasitologia , Vagina/parasitologia , Animais , Antinematódeos/uso terapêutico , Criança , Enterobíase/tratamento farmacológico , Enterobius/efeitos dos fármacos , Enterobius/isolamento & purificação , Feminino , Humanos , Mebendazol/uso terapêutico , Auditoria Médica , Períneo/fisiopatologia , Estudos Retrospectivos , Vagina/fisiopatologia , Vitória
10.
Ann Ig ; 24(1): 81-4, 2012.
Artigo em Italiano | MEDLINE | ID: mdl-22670340

RESUMO

The present study examines the most common home remedies in the Piedmont region of northwest Italy currently used in the treatment of pediatric enterobiasis, commonly known as pinworm infection. The remedies in question, typically based on popular beliefs and as such are nearly useless, were noted through interviews with subjects who had come to the local Hygiene and Public Health Services offices for information about pinworm prevention and treatment. Analysis of replies by the subjects clearly indicates that local families are ill-prepared to recognize the symptoms this parasitic infection; often it is confused with pediatric ketosis, therefore leading to inappropriate treatment which at times may be potentially harmful to the patient.


Assuntos
Antinematódeos/uso terapêutico , Artemisia absinthium , Enterobíase/tratamento farmacológico , Alho , Medicina Tradicional , Fitoterapia , Santonina/uso terapêutico , Animais , Criança , Pré-Escolar , Cultura , Enterobius/efeitos dos fármacos , Feminino , Humanos , Itália , Masculino , Mebendazol/uso terapêutico , Medicina Tradicional/métodos , Fitoterapia/métodos , Estudos Retrospectivos , Inquéritos e Questionários
11.
Pediatr Dermatol ; 29(2): 229-30, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-21906155

RESUMO

Cutaneous mastocytosis in children has an indolent course and undergoes spontaneous regression. Many triggering factors may cause mast cell degranulation and clinical manifestations. Knowledge of these factors is important for patients and their families. We report a case of exacerbation of urticaria pigmentosa due to mast cell degranulation caused by Enterobius vermicularis, which has not been reported before as a triggering factor.


Assuntos
Enterobíase/diagnóstico , Enterobius/isolamento & purificação , Mastocitose Cutânea/patologia , Mastocitose Cutânea/parasitologia , Animais , Antinematódeos/uso terapêutico , Criança , Progressão da Doença , Enterobíase/tratamento farmacológico , Enterobius/efeitos dos fármacos , Eosinófilos , Humanos , Imunoglobulina E/sangue , Masculino , Mastocitose Cutânea/tratamento farmacológico , Mebendazol/uso terapêutico , Resultado do Tratamento , Urticaria Pigmentosa/diagnóstico , Urticaria Pigmentosa/tratamento farmacológico
13.
Asian Pac J Trop Med ; 4(4): 315-9, 2011 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-21771477

RESUMO

OBJECTIVE: To investigate the relationship between enterobiasis and enuresis before and after albendazole therapy among 632 children, aged, 5-14 years, in Calabar, Nigeria. METHODS: The scotch tape (cellotape) technique was used for the detection of eggs of Enterobius vermicularis (E. vermicularis) while questionnaire-based interviews were used for screening for anal itching and/or enuresis among study participants. All subjects found positive for Enterobius infection as confirmed by the presence of eggs and those with persistent anal itching (both enuretic and non-enuretic) were treated with 400 mg of albendazole given as a single dose. The treated subjects were re-assessed post-treatment to ascertain whether they were cured and also to determine their enuretic status (for the enuretics). RESULTS: The overall prevalences of Enterobius infection, anal itching, and enuresis prior to albendazole therapy were 6.8%, 42.9%, and 35.6% respectively. There was no statistically significant difference in the prevalence of these parameters by the socio-economic class of subjects (P = 0.462, P = 0.647, and P = 0.610, respectively). The pre-treatment prevalences of enuresis among Enterobius and anal itching-positive subjects were 53.5% and 49.8%, respectively versus 34.3% and 24.9%, respectively among their negative counterpart (P = 0.012 and P < 0.001, respectively). Four (20%) out of the 20 enuretic children found Enterobius egg-negative after albendazole therapy were equally cured while 8(40%) had reduction of their enuresis, thus giving a total resolution rate of 60%. Similarly, 64.2% resolution (25% cure and 32.8% reduction) of enuresis was observed amongst 120 anal itching-cured/enuretic children. Enuretic status of the Enterobius-/anal itching-uncured subjects, on the other hand, remained unchanged post-treatment. CONCLUSIONS: This study is suggestive of the involvement of E. vermicularis in the aetiology of enuresis in Calabar. Children presenting with, especially, uncomplicated enuresis should be screened for enterobiasis.


Assuntos
Albendazol/administração & dosagem , Anti-Helmínticos/administração & dosagem , Enterobíase/complicações , Enterobíase/epidemiologia , Enterobius/patogenicidade , Enurese/complicações , Enurese/epidemiologia , Adolescente , Animais , Criança , Pré-Escolar , Enterobíase/tratamento farmacológico , Enterobius/efeitos dos fármacos , Enurese/etiologia , Feminino , Humanos , Masculino , Nigéria/epidemiologia , Contagem de Ovos de Parasitas , Prevalência , Inquéritos e Questionários
16.
J Hosp Med ; 4(2): 137-9, 2009 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-19219921

RESUMO

Enterobius vermicularis is the most common helminthic infection in the US. It is usually considered an innocuous parasite that at the most causes perianal itching. We report a case of an 84-year-old female patient from an assisted living facility who presented with symptoms of colitis for 2 months. On detailed history and exam, she was found to have E. vermicularis infection. All her symptoms resolved dramatically within 2 days after a single dose of albendazole. We want to emphasize the importance of including parasitic infections such as E. vermicularis in the differential diagnoses of patients presenting with symptoms of colitis.


Assuntos
Colite/diagnóstico , Diarreia/diagnóstico , Enterobíase/diagnóstico , Enterobius/isolamento & purificação , Dor Abdominal/diagnóstico , Dor Abdominal/parasitologia , Idoso de 80 Anos ou mais , Albendazol/administração & dosagem , Albendazol/uso terapêutico , Animais , Anti-Helmínticos/administração & dosagem , Anti-Helmínticos/uso terapêutico , Colite/tratamento farmacológico , Colite/parasitologia , Diagnóstico Diferencial , Diarreia/tratamento farmacológico , Diarreia/parasitologia , Enterobíase/tratamento farmacológico , Enterobius/efeitos dos fármacos , Feminino , Humanos
17.
Artigo em Inglês | MEDLINE | ID: mdl-18564704

RESUMO

In this study, adult patients were treated with praziquantel to expel intestinal flukes. Unexpectedly, dozens of adult Enterobius vermicularis worms with disfigured morphology, which had not been detected on fecal examination using Kat's modified thick-smear technique, were expelled from 6 of 33 patients.


Assuntos
Anti-Helmínticos/uso terapêutico , Enterobíase/diagnóstico , Enterobíase/tratamento farmacológico , Enterobius/efeitos dos fármacos , Praziquantel/uso terapêutico , Adulto , Idoso , Idoso de 80 Anos ou mais , Animais , Enterobíase/epidemiologia , Humanos , Achados Incidentais , Programas de Rastreamento , Pessoa de Meia-Idade , Prevalência , Tailândia/epidemiologia , Infecções por Trematódeos/tratamento farmacológico , Infecções por Trematódeos/epidemiologia
18.
Clin Pediatr (Phila) ; 47(4): 397-9, 2008 May.
Artigo em Inglês | MEDLINE | ID: mdl-18424563

RESUMO

Pinworm infection is a very common diagnosis in young children that is not always confirmed through laboratory evaluation before empiric therapy is prescribed. This article describes a toddler who was treated several times for pinworms because small white worms were seen in her perianal area. Laboratory analysis of parasite material found in her diaper later confirmed a diagnosis of dipylidiasis. Because the signs of dipylidiasis and pinworm infection overlap and the treatments for these parasitic infections are different, the laboratory should clinically confirm suspected persistent or recurrent pinworms.


Assuntos
Cestoides/isolamento & purificação , Infecções por Cestoides/diagnóstico , Enterobíase/diagnóstico , Enterobius/isolamento & purificação , Animais , Antinematódeos/uso terapêutico , Cestoides/efeitos dos fármacos , Infecções por Cestoides/tratamento farmacológico , Infecções por Cestoides/parasitologia , Pré-Escolar , Diagnóstico Diferencial , Enterobíase/tratamento farmacológico , Enterobíase/parasitologia , Enterobius/efeitos dos fármacos , Feminino , Humanos , Mebendazol/uso terapêutico , Prevenção Secundária
19.
J Am Assoc Lab Anim Sci ; 45(6): 35-9, 2006 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-17089989

RESUMO

Fenbendazole is commonly used in laboratory animal medicine as an anthelmintic for elimination of pinworms. It is generally regarded as a safe drug with minimal side effects. In our facility, 2 breeding colonies of rats were treated with fenbendazole to eliminate pinworms. Analysis of the breeding records revealed that feeding Sprague-Dawley rats a diet containing fenbendazole on a continuous basis for 7 consecutive weeks was associated with a significant reduction in litter size. Although the mechanism underlying this effect is unknown, the finding prompts caution when using fenbendazole to treat valuable breeding colonies or strains that are poor breeders.


Assuntos
Anti-Helmínticos/efeitos adversos , Fenbendazol/efeitos adversos , Tamanho da Ninhada de Vivíparos/efeitos dos fármacos , Ratos Sprague-Dawley , Animais , Anti-Helmínticos/administração & dosagem , Anti-Helmínticos/uso terapêutico , Cruzamento , Enterobius/efeitos dos fármacos , Feminino , Fenbendazol/administração & dosagem , Fenbendazol/uso terapêutico , Gravidez , Ratos , Ratos Sprague-Dawley/parasitologia , Ratos Sprague-Dawley/fisiologia , Estudos Retrospectivos
20.
Artigo em Chinês | MEDLINE | ID: mdl-16866136

RESUMO

OBJECTIVE: To study the therapeutic effect and possible adverse effects of tribendimidine enteric coated tablets in the treatment of infections due to hookworms, Ascaris lumbricoides, Trichuris trichiura, Enterobius vermicularis. METHODS: According to the standard clinical trial design and protocol, persons infected with hookworms, Ascaris lumbricoides, Trichuris trichiura, or Enterobius vermicularis respectively, were treated with tribendimidine enteric coated tablets in four counties of Guangdong and Jiangsu Provinces, albendazole was used as control. RESULTS: For hookworm infection, the curative rate (eggs negative in the faeces) were 89.5% (85/95) and 70.6% (60/85) with tribendimidine (400 mg) and albendazole(400 mg) respectively; for Ascaris infection, 97.4% (114/117) and 98.9% (91/92) with tribendimidine(300 mg) and albendazole(400 mg) respectively; for Trichuris infection, 33.3% (25/75) and 56.1% (23/41) with tribendimidine(400 mg/day for 3 days) and albendazole(400 mg/day for 3 days) respectively; for Enterobius infection in children, 74.1% (60/81) and 93.0% (40/43) with tribendimidine(200 mg) and albendazole(200 mg) respectively. No considerable side effect was found. CONCLUSION: Tribendimidine is highly active in the treatment of hookworm, Ascaris lumbricoides infections, free of major adverse effect and easy to administer. It is more effective than albendazole for the infection of Necator americanus.


Assuntos
Enteropatias Parasitárias/tratamento farmacológico , Infecções por Nematoides/tratamento farmacológico , Fenilenodiaminas/uso terapêutico , Adolescente , Adulto , Idoso , Albendazol/uso terapêutico , Ancylostomatoidea/efeitos dos fármacos , Animais , Ascaríase/tratamento farmacológico , Ascaris lumbricoides/efeitos dos fármacos , Criança , Método Duplo-Cego , Enterobíase/tratamento farmacológico , Enterobius/efeitos dos fármacos , Infecções por Uncinaria/tratamento farmacológico , Humanos , Pessoa de Meia-Idade , Necator americanus/efeitos dos fármacos , Comprimidos com Revestimento Entérico , Resultado do Tratamento , Tricuríase/tratamento farmacológico , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...